Authors: | Yabe, M.; Dogan, A.; Horwitz, S. M.; Moskowitz, A. J. |
Article Title: | Angioimmunoblastic T-cell lymphoma |
Abstract: | Angioimmunoblastic T-cell lymphoma (AITL) is one of the most common types of T-cell lymphoma, representing about 15–20% of cases of peripheral T-cell lymphoma (PTCL). It is characterized by a unique clinical presentation and distinct pathologic and molecular features. Classes of drugs particularly active in AITL are emerging; however, treatment of relapsed and refractory disease remains a challenge. This chapter reviews the epidemiology, clinical presentation, pathogenesis, diagnosis, and treatment of AITL. © Springer Nature Switzerland AG 2019. |
Keywords: | treatment; pathology; angioimmunoblastic t-cell lymphoma; follicular helper t-cell |
Journal Title: | Cancer Treatment and Research |
Volume: | 176 |
ISSN: | 0927-3042 |
Publisher: | Springer |
Date Published: | 2019-01-01 |
Start Page: | 99 |
End Page: | 126 |
Language: | English |
DOI: | 10.1007/978-3-319-99716-2_5 |
PUBMED: | 30596215 |
PROVIDER: | scopus |
DOI/URL: | |
Notes: | Chapter 5 in "T-Cell and NK-Cell Lymphomas: From Biology to Novel Therapies" (ISBN: 978-3-319-99715-5) -- Export Date: 1 February 2019 -- Source: Scopus |